COVID Vaccine in Patients With Cancer: NCCN Outlines Priorities medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Medexus Pharmaceuticals and medac GmbH enter into a License Agreement for First-in-Class .
Medexus Pharmaceuticals IncFebruary 2, 2021 GMT
Orphan Designated Drug with August 2021 PDUFA date
Management to host conference call at 10:00 AM Eastern Time on February 3, 2021 and
Key Opinion Leader webinar to be held at 2:00 PM Eastern Time on February 5, 2021
TORONTO and CHICAGO and MONTREAL and WEDEL, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) Medexus Pharmaceuticals Inc. (“Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) is pleased to announce that it and its wholly-owned United States-based subsidiary, Medexus Pharma, Inc. (“Medexus Pharma” and together with Medexus, the “Company”) entered into a Commercialization and Supply Agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. (“medac”), pursuant to which medac has granted Medexus Pharma an excl
President
Curt Gimmestad, vice president of industry engagement at Absher Construction Co., started with the company as a project engineer in 1993. Gimmestad has served the AGC in many capacities, including first vice president in 2019, an association trustee, and an instructor and executive board member for the Education Foundation. He also is a member of the Association for Learning Environments and the Capital Advisory Review Board’s Project Review Committee.
Stephens
First Vice President
Dawn Stephens is the CFO of Charter Construction, where she oversees financial processes and operations. Her career as a finance professional spans more than 25 years at several construction and real estate firms. In 2006, Stephens joined Harbor Properties as corporate controller and later became CFO. She is active in Commercial Real Estate Women, is past president of the Puget Sound Chapter of the Construction Financial Managers Association, and serves on several committees benefitin
Washington experts on the hard-won lessons of COVID’s first year
From treating patients to tracking the virus to vaccinations, health workers reflect on what they’ve learned and the challenges ahead. By Hannah Weinberger, Crosscut
Share: Swedish Medical Center health care workers battling the coronavirus outbreak look on from inside the hospital as first responders gathered outside in support of them in Seattle in April. The COVID-19 pandemic was Washington state s top story for 2020. (AP Photo/Elaine Thompson, File)
There’s a lot Dr. Jeff Duchin didn’t expect a year ago. “If I had seen what was coming, I might have considered retiring,” says the health officer with Public Health Seattle & King County, who hasn’t taken a day off since the first case of COVID-19 in the U.S. was confirmed a year and a day ago in nearby Snohomish.
Sacituzumab Govitecan – Another Antibody Drug Conjugate Carving out a Path in Genitourinary Oncology
Published 01 February 2021
I have previously discussed the use of antibody-drug conjugates for selective tumor cell intensification of urothelial carcinoma therapy in a Urotoday Clinical Trials Portal article.
1 Similarly, I’ve also focused on enfortumab vedotin before, and enfortumab vedotin is now FDA approved on the accelerated pathway for patients with locally advanced or metastatic urothelial carcinoma in the post-platinum chemotherapy and post-PD-(L1) antibody therapy setting.
2 Yet, even as new data continues to emerge on the use of enfortumab vedotin in various settings, we should take time to evaluate the development of other promising antibody-drug conjugates.